Chronic Lower Back Pain Market Revenue Anticipated To Reach $10.05 Billion By 2030 With 4.6% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Chronic Lower Back Pain Market By 2030 Based On Its 2026 Value?

The chronic lower back pain market size has experienced consistent expansion in recent years. Projections indicate it will grow from $8.04 billion in 2025 to $8.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.6%. The historical growth can be attributed to an increasing aging population, a rising prevalence of musculoskeletal disorders, evolving sedentary lifestyles, a higher incidence of workplace-related back injuries, and expanded access to diagnostic imaging.

The chronic lower back pain market is anticipated to experience consistent expansion over the next few years. It is projected to achieve a size of $10.06 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.6%. This growth during the forecast period is primarily driven by factors such as the increasing demand for non-invasive therapies, the escalating adoption of digital therapeutics, the broadening of outpatient pain management services, a heightened emphasis on personalized medicine, and augmented investments in chronic pain research. Key trends anticipated in the forecast period encompass the increasing embrace of multimodal pain management approaches, the rising utilization of minimally invasive interventions, the expanded integration of digital pain monitoring tools, the development of more personalized treatment pathways, and an intensified focus on non-opioid therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

What Market Drivers Are Helping Shape The Chronic Lower Back Pain Market Expansion?

The chronic lower back pain market is anticipated to expand as the geriatric population increases. This demographic refers to individuals aged 65 years and above. Within this group, age-related neurodegenerative and musculoskeletal conditions, such as arthritis and osteoarthritis, progress rapidly, leading to weakness and painful complaints that result in chronic back pain and reduced physical activities. For instance, data from May 2024 by the Administration for Community Living, a US government agency, showed that in 2022, 17.3% of the population was 65 or older, and this percentage is projected to rise to 22% by 2040. Consequently, the expanding geriatric population is a significant driver for the growth of the chronic lower back pain market.

Which Segment Divisions Form The Structure Of The Chronic Lower Back Pain Market?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types Of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

Which Trends Are Influencing The Direction Of The Chronic Lower Back Pain Market?

Key companies in the chronic lower back pain market are creating offerings with advanced technologies, such as BurstDR SCS technology, to present new alternatives for patients. BurstDR SCS technology is an exclusive spinal cord stimulation (SCS) treatment designed to alter pain signals as they move from the spinal cord to the brain through the use of mild electrical pulses. For example, in May 2023, Abbott Laboratories, a US-based medical device enterprise, obtained FDA approval for its Spinal Cord Stimulation (SCS) devices, including the Proclaim SCS Family and the Eterna SCS System, for addressing chronic back pain. Abbott’s SCS devices utilize its proprietary BurstDR stimulation waveform, a superior therapy formulated to more closely mimic how pain signals reach the brain and to alleviate the emotional suffering associated with pain, unlike standard tonic stimulation.

Which Companies Form The Competitive Landscape Of The Chronic Lower Back Pain Market?

Major companies operating in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Access The Complete Chronic Lower Back Pain Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Which Geographic Region Represents The Largest Chronic Lower Back Pain Market Share?

North America was the largest region in the chronic lower back pain market in 2025. The regions covered in the chronic lower back pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Lower Back Pain Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp

Browse Through More Reports Similar to the Global Chronic Lower Back Pain Market 2026, By The Business Research Company

Liver Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Hepatitis Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Fatty Liver Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795